KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Assets (2021 - 2025)

Aurinia Pharmaceuticals' Return on Assets history spans 5 years, with the latest figure at 0.45% for Q4 2025.

  • For Q4 2025, Return on Assets rose 44.0% year-over-year to 0.45%; the TTM value through Dec 2025 reached 0.45%, up 44.0%, while the annual FY2025 figure was 0.44%, 43.0% up from the prior year.
  • Return on Assets reached 0.45% in Q4 2025 per AUPH's latest filing, up from 0.15% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.45% in Q4 2025 to a low of 0.51% in Q3 2021.
  • Average Return on Assets over 5 years is 0.13%, with a median of 0.14% recorded in 2023.
  • Peak YoY movement for Return on Assets: increased 5bps in 2024, then surged 44bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.4% in 2021, then surged by 44bps to 0.23% in 2022, then skyrocketed by 37bps to 0.14% in 2023, then surged by 107bps to 0.01% in 2024, then soared by 4194bps to 0.45% in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Return on Assets are 0.45% (Q4 2025), 0.15% (Q3 2025), and 0.12% (Q2 2025).